Bajaj HealthCare stock | 2026 earnings growth & current analysis

Bajaj HealthCare

BSE:539872

Rp 289,75

Rp0,00 (0,00%)

289,75 Rp

Rp0,00 (0,00%)

End-of-day quote: 04/01/2026

Bajaj HealthCare Stock Value

Analysts currently rate BSE:539872 as sf_Data Unavailable.

Bajaj HealthCare Company Info

EPS Growth 5Y

0,00%

Market Cap

Rp9,15 B

Long-Term Debt

Rp0,39 B

Annual earnings

05/28/2026

Dividend

Rp1,01

Dividend Yield

0,35%

Founded

1993

Industry

Materials

Country

India

Website

Bajaj HealthCare

ISIN Number

INE411U01027

Website

http://www.bajajhealth.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Bajaj HealthCare’s Price Target has risen from Rp0,00 to Rp289,75 - a 100,00% increase.

Top growth stocks in the materials sector (5Y.)

What does Bajaj HealthCare do?

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredients, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries. Business Segments The company engages in a single principal business activity: the manufacturing and sales of pharmaceuticals, which accounts for 100% of its turnover. With a robust operational infrastructure, the company operates multiple manufacturi...

Business Segments

The company engages in a single principal business activity: the manufacturing and sales of pharmaceuticals, which accounts for 100% of its turnover. With a robust operational infrastructure, the company operates multiple manufacturing plants strategically located across India.

Moreover, the company is committed to research and development, which is a cornerstone of its business strategy. By investing in R&D, the company focuses on developing new pharmaceutical formulations and enhancing existing products to cater to the evolving needs of the healthcare industry.

Business Strategy

The company’s business strategy revolves around maintaining its leadership position in the pharmaceutical manufacturing sector. The company embraces innovation as a critical driver of growth, with an overarching aim to enhance the quality and effectiveness of its products.

Investments in research and development are integral to the company’s long-term vision. The focus on developing innovative pharmaceutical solutions allows the company to meet the increasing demand for medications and related healthcare products. By remaining responsive to market dynamics, the company is equipped to adapt its product offerings to suit healthcare advancements and regulatory requirements.

Additionally, the company prioritizes building enduring relationships with healthcare professionals and institutions. It seeks feedback from these stakeholders to improve its product line and services continually. Regular consumer satisfaction surveys further enhance understanding of market needs, allowing the company to refine its strategies and operations.

Market expansion remains a pivotal component of the company's strategy. By actively pursuing opportunities in emerging markets, the company aims to increase its footprint globally while also optimizing domestic market penetration. The company adopts a carefully measured approach to entering new geographical markets, assessing potential risks and ensuring compliance with local regulations before proceeding.

Products and Services

The company specializes in manufacturing a wide range of pharmaceutical products. The company's product offerings encompass various therapeutic areas, targeting a broad spectrum of health conditions. This includes prescription medications, over-the-counter products, and other health-related formulations.

Geographical Markets Served

The company has established a significant presence in both the domestic and international markets. The company operates in 26 states across India, demonstrating a strong national footprint. Furthermore, the company extends its reach to over 62 countries worldwide, affirming its capabilities in international markets.

Customers

The company primarily serves a diverse customer base, including healthcare professionals, hospitals, clinics, and individual patients.

Sales and Marketing

The company employs diverse sales and marketing strategies aimed at maximizing market penetration and brand visibility. The company combines direct sales through professional healthcare representatives with strategic marketing campaigns designed to reach relevant stakeholders.

By engaging directly with healthcare professionals, the company ensures that its products are recommended based on merit and efficacy. Marketing approaches are continuously adapted to align with the latest trends and technologies in pharmaceutical marketing emphasizing educational content that builds trust and reliability in its brand.

History

Bajaj HealthCare Limited was founded in 1993. The company was incorporated in 1993.

New support ticket

Explore

Bajaj HealthCare Stock Value

Bajaj HealthCare Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Bajaj HealthCare do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Bajaj HealthCare Stock Value

Bajaj HealthCare Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Bajaj HealthCare do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.